贵州信邦制药股份有限公司 关于变更签字注册会计师的公告

Group 1 - The company has appointed Xu Ruixing as the new signing auditor for the 2025 financial year, replacing Yu Yongchun who has left the firm [2][3] - The audit firm, Beijing Dehao International, will continue to provide financial and internal control audits for the company in 2025 [2][3] - The transition of responsibilities during the change of signing auditor has been orderly, ensuring no adverse impact on the 2025 financial report audit [6] Group 2 - The company and its subsidiaries need to pay a total of 50.79 million yuan in tax and late fees, with the company itself responsible for 2.70 million yuan and subsidiaries for 48.09 million yuan [8][9] - This tax payment will be recorded in the company's 2025 profit and loss statement, but it will not affect prior financial data adjustments [9] - The tax payment will not impact the company's normal operations [9]